Merger Advantage Orbit Biomedical's merger with Gyroscope Therapeutics positions them uniquely as a leading retinal gene therapy company, with integrated capabilities and advanced technology, creating potential partnership opportunities.

Cutting-Edge Surgical Platform Orbit Biomedical's focus on precise, targeted surgical delivery to the sub-retinal space sets a new standard in gene and cell therapy treatment, presenting a competitive edge that appeals to medical centers seeking innovative solutions.

Strategic Market Access Operating out of US and UK locations, Orbit Biomedical has the advantage of strategic market access to both regions, offering potential expansion opportunities and access to diverse patient populations.

High-Quality Manufacturing With a strong emphasis on high-quality manufacturing, Orbit Biomedical ensures the consistent delivery of treatments to patients with blinding conditions, creating an attractive proposition for medical institutions focused on quality outcomes.

Advanced Tech Stack Orbit Biomedical's advanced technology stack, including W3 Total Cache, WordPress, MySQL, and more, demonstrates a commitment to technological innovation, appealing to tech-savvy medical facilities looking for cutting-edge solutions.